Neurava Inc. has filed a notice of an exempt offering of securities to raise $7 Million in New Funding.
According to filings with the U.S. Securities and Exchange Commission, Neurava Inc. is raising up to $7,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About Neurava Inc.
Founded in 2019 by Vivek Ganesh, PhD and Jay Shah, PhD and with the addition of Trevor Meyer, PhD, Neurava’s mission is to develop and deliver breakthrough wearable technology that can fundamentally transform outcomes in areas of unmet clinical need, beginning with epilepsy. Leveraging a deep background in neuromodulation and epilepsy, we have since grown into a multidisciplinary team, combining deep medical device experience with a culture and mindset focused on transformational innovation. Our AI-powered wearable platform is a novel approach aiming to monitor the entire continuum beginning with seizures and any induced cardiorespiratory dysfunctions, to ultimately mitigate the risk of SUDEP and provide peace of mind to families and individuals living with epilepsy.
To learn more about Neurava Inc., visit https://www.neurava.com/
Neurava Inc. Linkedin Page: https://www.linkedin.com/company/neurava/
Contact:
Jay Shah, Co-Chief Executive Officer
281-995-8055
https://www.linkedin.com/in/-jay-shah/
SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.
